John Waites, MD

Thrombocytopenia
Thrombocytopenia
05/21/2013
Aditya M. Sharma, MD; John Waites, MD
<p><img alt="" src="/sites/default/files/generic%20icon2_1.jpg" style="height:115px; width:115px; float:left" />Unfractionated heparin (UFH) and low molecular...
05/21/2013
Thrombocytopenia
Thrombocytopenia
05/21/2013
Aditya M. Sharma, MD; John Waites, MD
<p><img alt="" src="/sites/default/files/generic%20icon2_1.jpg" style="height:115px; width:115px; float:left" />Unfractionated heparin (UFH) and low molecular...
05/21/2013
PAD
PAD
07/08/2014
Aditya M. Sharma, MD; John Waites, MD; Amit Jain, MD; Kanwar Singh, MD, FHRS
Peripheral arterial disease (PAD) is a condition characterized by atherosclerotic narrowing or occlusion of the arteries, reducing blood flow to the limbs.
07/08/2014
PAD
PAD
07/08/2014
Aditya M. Sharma, MD; John Waites, MD; Amit Jain, MD; Kanwar Singh, MD, FHRS
Peripheral arterial disease (PAD) is a condition characterized by atherosclerotic narrowing or occlusion of the arteries, reducing blood flow to the limbs.
07/08/2014
PAD
PAD
07/08/2014
Aditya M. Sharma, MD; John Waites, MD; Amit Jain, MD; Kanwar Singh, MD, FHRS
Peripheral arterial disease (PAD) is a condition characterized by atherosclerotic narrowing or occlusion of the arteries, reducing blood flow to the limbs.
07/08/2014
PAD
PAD
07/08/2014
Aditya M. Sharma, MD; John Waites, MD; Amit Jain, MD; Kanwar Singh, MD, FHRS
Peripheral arterial disease (PAD) is a condition characterized by atherosclerotic narrowing or occlusion of the arteries, reducing blood flow to the limbs.
07/08/2014